// App-Quantinova.ai

SAT-1034 : Severe Acanthosis Nigricans and Diabetes Resolution after Immunosuppresion in Latin-American Female with Multiple Autoimmune Disorders

Researchers

Presenter

  • Miguel Pasquel

Principal Investigators

  • Alvaro Ontaneda

  • Nicolas Jara

  • Patricia Duran

  • Luis Narvaez

  • Francisco J Pasquel

Medical Centers

  • Emory University School of Medicine, Atlanta, GA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Acanthosis Nigricans

  • Rheumatoid arthritis

  • Juvenile dermatomyositis

  • Hypothyroidism

  • Hyperglycemia

  • Inflammatory Arthritis

  • Diabetes

Biomarkers

  • C-peptide

  • Hemoglobin A1c

  • Insulin

  • Body mass index

Drug/Treatment

  • Insulin glargine

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Insulin Aspart

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Prednisone

  • Rituximab

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final